Source: Eur Respir J, 57 (3) 2001829; 10.1183/13993003.01829-2020
Disease area: Paediatric lung diseases, Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Peter M. Mourani, Marci K. Sontag, Kayla M. Williamson, J. Kirk Harris, Ron Reeder, Chris Locandro, Todd C. Carpenter, Aline B. Maddux, Katherine Ziegler, Eric A.F. Simões, Christina M. Osborne, Lilliam Ambroggio, Matthew K. Leroue, Charles E. Robertson, Charles Langelier, Joseph L. DeRisi, Jack Kamm, Mark W. Hall, Athena F. Zuppa, Joseph Carcillo, Kathleen Meert, Anil Sapru, Murray M. Pollack, Patrick McQuillen, Daniel A. Notterman, J. Michael Dean, Brandie D. Wagner. Temporal airway microbiome changes related to ventilator-associated pneumonia in children. Eur Respir J, 57 (3) 2001829; 10.1183/13993003.01829-2020

Member's Comments

No comment yet.

Related content which might interest you: The lung bacterial microbiome in community-acquired and nosocomial pneumonia Source: Eur Respir Monogr 2019; 83: 188-194 Year: 2019 Respiratory infections in the immunocompetent host: from asthma exacerbations to hospital-acquired pneumonia Source: Annual Congress 2007 - Infections year in review Year: 2007 Challenges in the management of hospital-acquired pneumonia including ventilator-associated pneumonia Source: ERS Course 2018 - Respiratory Infections Year: 2018 Cytokine responses, microbial etiology and short-term outcome in community-acquired pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis Source: Eur Respir J 2016; 48: 1329-1339 Year: 2016 How to prevent ventilator-associated pneumonia Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies Year: 2013 Reducing antibiotics use for ventilator-associated pneumonia in brain-injured patients Source: Eur Respir J 2016; 47: 1060-1061 Year: 2016 Seasonal variation in outcome for hospitalised patients with community-acquired pneumonia Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Microbial investigation in ventilator-associated pneumonia Source: Eur Respir J 2001; 17: 791-801 Year: 2001 Estimation of inflammatory process activity in community-acquired pneumonia Source: Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations Year: 2010 Evidence on measures for the prevention of ventilator-associated pneumonia Source: Eur Respir J 2007; 30: 1193-1207 Year: 2007 Common pathogens in bronchial secretions of the ICU patients with nosocomial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 405s Year: 2001 The post-tuberculosis lung changes as risk factor of the community-acquired pneumonia delayed course Source: Eur Respir J 2006; 28: Suppl. 50, 351s Year: 2006 Preventing ventilator-associated pneumonia Source: International Congress 2017 – PG12 Life-threatening pulmonary infections Year: 2017 Cardiovascular consequences of community-acquired pneumonia and other pulmonary infections Source: Eur Respir Monogr 2020; 88: 212-228 Year: 2020 The impact of inflammatory-response in the outcome of trauma patients with and without ventilator-associated pneumonia Source: Eur Respir J 2004; 24: Suppl. 48, 232s Year: 2004 Is ventilated hospital-acquired pneumonia a worse entity than ventilator-associated pneumonia? Source: Eur Respir Rev, 29 (157) 200023; 10.1183/16000617.0023-2020 Year: 2020 Comparison of costs of community-acquired pneumonia (CAP) treatment at patients with and without bronchial obstruction Source: Annual Congress 2011 - COPD management Year: 2011 Effects of glucocorticoids in ventilated piglets with severe pneumonia Source: Eur Respir J 2008; 32: 1037-1046 Year: 2008 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011